In a clinical practice guideline issued by the American Thoracic Society, together with the European Respiratory Society, Japanese Respiratory Society, and Asociacion Latinoamericana de Torax, updated recommendations are ...
May 10, 2022
0
3
Scientists at Duke-NUS Medical School and National Heart Center Singapore (NHCS), in collaboration with colleagues in Singapore and the UK, have shown that the human form of the signaling protein interleukin 11 (IL-11) has ...
Jun 18, 2021
0
15
Cologne University Hospital (UKK), University of Marburg (UMR), the German Center for Infection Research (DZIF) and Boehringer Ingelheim today announced the initiation of Phase 1/2a clinical investigation of BI 767551, a ...
Dec 18, 2020
0
3
Impaired function of lung fibroblast is considered causative for symptoms of the incurable lung disease COPD (Chronic Obstructive Pulmonary Disease). Using high-resolution epigenetic profiling, German and British scientists ...
May 24, 2023
0
3
Federal health regulators have approved a drug to reverse the blood-thinning effects of the popular pill Pradaxa, which has been subject to thousands of reports of severe bleeding.
Oct 16, 2015
0
18
(HealthDay)—The reduction in risk of cardiovascular (CV) death with empagliflozin is most mediated by changes in hematocrit and hemoglobin, according to research published online Dec. 4 in Diabetes Care.
Dec 26, 2017
0
6
For older versus younger adults, low- to moderate-intensity statins are associated with a greater reduction in low-density lipoprotein cholesterol (LDL-C), according to a study published online Aug. 1 in the Annals of Internal ...
Aug 1, 2023
0
0
For patients hospitalized for acute heart failure, treatment with the sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin produces clinical benefit, according to a study published online April 4 in Circulation ...
Apr 13, 2022
0
9
An international clinical trial involving Birmingham Professor Phil Newsome identified a promising target for patients with non-alcoholic steatohepatitis (NASH), as reported in a paper published yesterday (Nov. 6) in Nature ...
Nov 7, 2023
0
41
Federal health officials have approved a cheaper version of the world's top-selling insulin from Sanofi for millions of U.S. patients with diabetes.
Dec 16, 2015
0
3
